Trials / Completed
CompletedNCT05462470
Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 255 (actual)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
For patients with initially unresectable colorectal liver metastasis (IU-CRLM) receiving effective conversion therapy, disease relapse after conversion hepatectomy is common due to the extensive tumor load. Yet, few studies have focused on the assessment and management of relapse after conversion hepatectomy for IU-CRLM. This study aimed to investigate the impact of surgical management for relapse after conversion hepatectomy in IU-CRLM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Repeat Liver Surgery | repeat liver surgery included not only hepatectomy, but also ablative treatment, including radiofrequency ablation (RFA) and microwave ablation (MWA) |
| PROCEDURE | Non-Repeat Liver Surgery | Systemic palliative chemotherapy |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2022-04-30
- Completion
- 2022-04-30
- First posted
- 2022-07-18
- Last updated
- 2022-07-19
Source: ClinicalTrials.gov record NCT05462470. Inclusion in this directory is not an endorsement.